Chemotherapy-Induced Alopecia: An Exploratory Questionnaire-Based Study from Israel Comparing Knowledge, Attitudes, and Management Practices Among Dermatologists and Oncologists

This exploratory study from Israel surveyed 103 healthcare providers, including 60 dermatologists and 43 oncologists, to assess their knowledge, attitudes, and management practices regarding chemotherapy-induced alopecia (CIA) and its persistent form (pCIA). The study found that oncologists had a better understanding of CIA, particularly in identifying causative factors and the use of scalp cooling, while dermatologists were more knowledgeable about pCIA. Significant knowledge gaps were identified in both groups, with gender being a predictor of knowledge levels. The study highlighted the need for improved education, standardized referral pathways, and interdisciplinary collaboration to enhance patient care, while also addressing logistical and financial barriers. Future research with larger and more diverse samples is recommended.